Schwartz GK - Search Results

1

Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts.

Motwani M, Jung C, Sirotnak FM, She Y, Shah MA, Gonen M, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Clin Cancer Res. 2001 Dec;7(12):4209-19. Clin Cancer Res. 2001. PMID: 11751522

2

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.

Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Kelsen DP, Fuks Z, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1394-9. doi: 10.1093/jnci/87.18.1394. J Natl Cancer Inst. 1995. PMID: 7658500

3

A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.

Saltz L, Kemeny N, Schwartz G, Kelsen D. Saltz L, et al. Cancer. 1994 Aug 1;74(3):958-61. doi: 10.1002/1097-0142(19940801)74:3<958::aid-cncr2820740326>3.0.co;2-x. Cancer. 1994. PMID: 8039124 Clinical Trial.

4

Defining the invasive phenotype of proximal gastric cancer cells.

Schwartz GK, Wang H, Lampen N, Altorki N, Kelsen D, Albino AP. Schwartz GK, et al. Cancer. 1994 Jan 1;73(1):22-7. doi: 10.1002/1097-0142(19940101)73:1<22::aid-cncr2820730106>3.0.co;2-o. Cancer. 1994. PMID: 8275429

5

Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.

Casper ES, Christman KL, Schwartz GK, Johnson B, Brennan MF, Bertino JR. Casper ES, et al. Among authors: schwartz gk. Cancer. 1993 Aug 1;72(3):766-70. doi: 10.1002/1097-0142(19930801)72:3<766::aid-cncr2820720321>3.0.co;2-z. Cancer. 1993. PMID: 8392904 Clinical Trial.

6

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M. Kelsen D, et al. J Clin Oncol. 1996 Jun;14(6):1818-28. doi: 10.1200/JCO.1996.14.6.1818. J Clin Oncol. 1996. PMID: 8656250 Clinical Trial.

7

A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.

Schwartz GK, Christman K, Saltz L, Casper E, Quan V, Bertino J, Martin DS, Colofiore J, Kelsen D. Schwartz GK, et al. Cancer. 1996 Nov 1;78(9):1988-95. Cancer. 1996. PMID: 8909321 Clinical Trial.

8

The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines.

König A, Schwartz GK, Mohammad RM, Al-Katib A, Gabrilove JL. König A, et al. Among authors: schwartz gk. Blood. 1997 Dec 1;90(11):4307-12. Blood. 1997. PMID: 9373241 Free article.

9

A phase II study of topotecan administered five times daily in patients with advanced gastric cancer.

Saltz LB, Schwartz GK, Ilson DH, Quan V, Kelsen DP. Saltz LB, et al. Among authors: schwartz gk. Am J Clin Oncol. 1997 Dec;20(6):621-5. doi: 10.1097/00000421-199712000-00018. Am J Clin Oncol. 1997. PMID: 9391553 Clinical Trial.

10

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.

Elias AD, Wheeler C, Ayash LJ, Schwartz G, Ibrahim J, Mills L, McCauley M, Coleman N, Warren D, Schnipper L, Antman KH, Teicher BA, Frei E 3rd. Elias AD, et al. Clin Cancer Res. 1998 Jun;4(6):1443-9. Clin Cancer Res. 1998. PMID: 9626461 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters